BDRX

Biodexa Pharmaceuticals
BDRX

2 hedge funds and large institutions have $2.12M invested in Biodexa Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$748K
2
+$611K

Top Sellers

1
-$159K
2
-$97K
3
-$76K
4
Morgan Stanley
Morgan Stanley
New York
-$35K
5
Citadel Advisors
Citadel Advisors
Florida
-$32K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$748K
2
$611K
3
$301K
4
$197K
5
$104K
6
$69K
7
$52K
8
$22K
9
$13K
10
–
11
–